Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Autor: Jan van den Brande, Tessa Uiterwaal, Christianne J. Buskens, Juda Vecht, Robert E G J M Pierik, Job H.C. Peters, Nofel Mahmmod, John Maring, E. Joline de Groof, Toer W. Stevens, H. B. A. C. Stockmann, Pieter C. F. Stokkers, Karlien F. Bruin, Eric J. Hazebroek, Ailsa Hart, Arnold van de Laar, Hubert A Prins, Richard van Hillegersberg, Rachel L. West, Paul Kingma, Menno A. Brink, Pritesh Morar, Ruud Schouten, Marno C.M. Rijk, A Jeroen de Groof, Sijbrand Hofker, Annekatrien Depla, Bregje Mol, Janneke van der Woude, T. J. Gardenbroek, Janindra Warusavitarne, Bas Oldenburg, Edwin S. van der Zaag, Anna A. W. van Geloven, Rogier M P H Crolla, Emma J. Eshuis, Hans Brouwer, Meindert N. Sosef, Maria L Haasnoot, Geert R. D'Haens, Nynke Talstra, Marcel Spanier, Liekele Oostenbrug, Jeroen M. Jansen, Maarten J Boom, Donald L. van der Peet, Nanne K. H. de Boer, Willem A. Bemelman, Cyriel Y. Ponsioen, Rosalie C Mallant, Theo J.M. van Ditzhuijsen, Gerard Dijkstra, Alexander P.J. Houdijk, Willem A. Marsman, Djuna Cahen, Casper G. Noomen, Huib A. Cense, Esther C. J. Consten, Michael F. Gerhards, Ad A. van Bodegraven, Rob J. Lieverse, Andreas Marinelli, Sjoerd van der Werff, Clemens Bolwerk, Ernst Jan Spillenaar Bilgen, Quirijn A. J. Eijsbouts, Guido Mannaerts, Bart A. van Wagensveld

Publikováno v: The lancet. Gastroenterology & hepatology, 5(10), 900-907. HANLEY & BELFUS-ELSEVIER INC
LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited

BACKGROUND: The LIR!C trial showed that laparoscopic ileocaecal resection is a cost-effective treatment that has similar quality-of-life outcomes to treatment with infliximab, an anti-tumour necrosis factor (TNF) drug. We aimed to compare long-term o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e5752a7757a14a7ceff01b5b9c7a95a
https://doi.org/10.1016/s2468-1253(20)30117-5

Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial)

Autor: Ernst Jan Spillenaar Bilgen, Arnold van de Laar, Willem A Bemelman, Richard van Hillegersberg, Sjoerd D J van der Werf, Donald L. van der Peet, Rosalie C Mallant, C. Janneke van der Woude, Pascal E P Dekkers, Henricus B Stockmann, Annet M C J Voorburg, B W Marcel Spanier, A W Marc van Milligen de Wit, Juda Vecht, Huib A. Cense, Esther C. J. Consten, Liekele Oostenbrug, Quirijn A. J. Eijsbouts, Maarten J Boom, Menno A. Brink, Robert E G J M Pierik, Henk A van Heukelem, Willem A. Marsman, Martin H M G Houben, Bas Oldenburg, Mirjam A. G. Sprangers, Rogier M P H Crolla, Karien F Bruin, Clemens Bolwerk, Jan van den Brande, Michael F. Gerhards, Ad A. van Bodegraven, Dirk J. de Jong, Warner Bruins Slot, Andreas Marinelli, Hubert A Prins, Bart A. van Wagensveld, Robert P. Bleichrodt, Meindert N. Sosef, Djuna Cahen, Edwin S. van der Zaag, Laurents P. S. Stassen, Nancy A M van Ooteghem, Jeroen M Jansen, Paul H. P. Davids, Emma J. Eshuis, T Hauwy Goei, Theo J.M. van Ditzhuijsen, Anna A. W. van Geloven, Anne-Marie van Berkel, Patrick M.M. Bossuyt, Johan F. Lange, Pieter C. F. Stokkers, Rob J. Lieverse, John Maring

Publikováno v: Eshuis, E J, Bemelman, W A, van Bodegraven, A A, Sprangers, M A G, Bossuyt, P M M, van Milligen de Wit, A W M, Crolla, R M P H, Cahen, D L, Oostenbrug, L E, Sosef, M N, Voorburg, A M C J, Davids, P H P, van der Woude, C J, Lange, J, Mallant, R C, Boom, M J, Lieverse, R J, van der Zaag, E S, Houben, M H M G, Vecht, J, Pierik, R E G J, van Ditzhuijsen, T J M, Prins, H A, Marsman, W A, Stockmann, H B, Brink, M A, Consten, E C J, van der Werf, S D J, Marinelli, A W K S, Jansen, J M, Gerhards, M F, Bolwerk, C J M, Stassen, L P S, Spanier, B W M, Bilgen, E J, van Berkel, A M, Cense, H A, Van Heukelem, H A, van Laar, A, Slot, W B, Eijsbouts, QA, van Ooteghem, N A M, van Wagensveld, B, van den Brande, J M H, van Geloven, A A W, Bruin, K F, Maring, J K, Oldenburg, B, van Hillegersberg, R, Jong, D J, Bleichrodt, R, van der Peet, D L, Dekkers, P E P, Goei, T H & Stokkers, P C F 2008, ' Laparoscopic ileocolic resection versus infliximab treatment of distal ileitis in Crohn's disease: a randomized multicenter trial (LIR!C-trial) ', BMC Surgery, vol. 8, pp. 15 . https://doi.org/10.1186/1471-2482-8-15
BMC Surgery, 8, 15
BMC surgery, 8(1). BioMed Central
BMC Surgery, Vol 8, Iss 1, p 15 (2008)
BMC Surgery, 8. BioMed Central Ltd.
BMC Surgery, 8. BioMed Central
BMC Surgery, 8, pp. 15
BMC Surgery

Contains fulltext : 69534.pdf (Publisher’s version ) (Open Access) BACKGROUND: With the availability of infliximab, nowadays recurrent Crohn's disease, defined as disease refractory to immunomodulatory agents that has been treated with steroids, is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fa6e01ef95962f9b5b44d3615d7bc19
https://pure.eur.nl/en/publications/3fe44558-5801-46f8-9d9a-1dfabf907e2f